Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination.

Journal of viral hepatitis - 1 Mar 2026

You Chunfang, Diao Yuting, Tang Juan, Tang Jing, Deng Wei, Zheng Chunqi, Liao Dongxia, Song Dan, Wang Jie, Pu Yangyang

Abstract excerpt

Hepatitis C virus (HCV) micro-elimination faces challenges from fragmented care pathways, particularly in high-prevalence regions with complex genotypes and socioeconomic barriers. This study evaluated a simplified 'Test and Treat' (TNT) strategy to enhance in-hospital HCV micro-elimination by reducing delays and improving linkage to care. Outcomes including HCV RNA testing rates, treatment uptake rates, time to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Hospitals

Share to RNA, Viral

Share to Sustained Virologic Response

Source

Open in PubMed Open full text

Identifiers

PMID: 41664555
DOI: 10.1111/jvh.70150
PMCID: PMC12887545

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination.PMID 41664555Read ↗

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of GeorgiaSemantic proximity Read ↗

Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trialSemantic proximity Read ↗

The Cost-effectiveness of One-step Point-of-care Hepatitis C Virus RNA Testing in the United StatesSemantic proximity Read ↗

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.Semantic proximity Read ↗

Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial.Semantic proximity Read ↗

Interim impact evaluation of the hepatitis C virus elimination program in GeorgiaSemantic proximity Read ↗

Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based StudySemantic proximity Read ↗

Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.Semantic proximity Read ↗

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationSemantic proximity Read ↗

“We usually see a lot of delay in terms of coming for or seeking care”: an expert consultation on COVID testing and care pathways in low- and middle-income countriesSemantic proximity Read ↗

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity Read ↗

Clinical Samples with Delayed Processing Time are Associated with Lower HIV Viral Load Results in a High-Volume Regional Laboratory, Njombe Region, Tanzania (Oct 2024–Mar 2025)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.